AMZN Today - Jul 14: Free Cash Flow Concerns
カートのアイテムが多すぎます
ご購入は五十タイトルがカートに入っている場合のみです。
カートに追加できませんでした。
しばらく経ってから再度お試しください。
ウィッシュリストに追加できませんでした。
しばらく経ってから再度お試しください。
ほしい物リストの削除に失敗しました。
しばらく経ってから再度お試しください。
ポッドキャストのフォローに失敗しました
ポッドキャストのフォロー解除に失敗しました
-
ナレーター:
-
著者:
So, here’s the scoop. Amazon’s stock didn’t move much today, but there’s some chatter that’s got folks a little uneasy. The buzz is all about free cash flow – or, well, the lack of it. A piece from Trefis really highlighted how this silence on cash flow is reshaping the whole bull case for Amazon. Basically, if they can’t show us the money, people start to wonder if it’s worth holding onto.
On top of that, there’s some competition heating up. You’ve got HIMS stock taking a hit because Amazon’s diving into the GLP-1 game, which is all about weight-loss drugs – yeah, the whole Ozempic thing. Investors are paying attention to how this plays out, especially with earnings around the corner. And let’s not forget about the tech rivalry with SpaceX. Fortune pointed out that these two are kinda like tech twins worth a whopping $4.5 trillion, and they’re gearing up for a showdown. Just adds to the drama, right?
Also, Morgan Stanley raised their CapEx estimates for Amazon, which means they think Amazon will need to spend more on tech and infrastructure. That could mean more costs down the line, which isn’t exactly music to investors’ ears right now.
Oh, and there’s been some trimming on stock holdings by Leelyn Smith LLC. Just another little tidbit showing that not everyone’s feeling super bullish about Amazon right now.
So, yeah, it’s a mixed bag for AMZN. The free cash flow issue is definitely something to keep an eye on, especially with all the competition heating up in the healthcare and tech spaces.
Anyway, that’s the lowdown on Amazon today. Just remember, I’m here to keep you in the loop, not to give you financial advice. Stay curious and keep that investing spirit alive! Catch you later!
adbl_web_anon_alc_button_suppression_t1
まだレビューはありません